India is one of the world's largest suppliers of generic medicines. Behind that scale is a quality framework that separates reliable manufacturers from the rest, and at its centre is WHO-GMP certification.
For pharmaceutical companies sourcing manufacturing partners, understanding what WHO-GMP actually requires is an important first step toward choosing the right facility.
What WHO-GMP certification covers
WHO-GMP stands for World Health Organization Good Manufacturing Practice. It is a set of internationally recognised standards governing how pharmaceutical products are produced, tested, documented, and released for distribution.
A WHO-GMP certified facility has demonstrated compliance across every stage of manufacturing, from raw-material sourcing and production-environment controls through quality testing, batch documentation, and product release protocols.
Certification is not a one-time achievement. Manufacturers are subject to periodic inspections and must maintain compliance continuously. Deviations in process, documentation, or facility standards can affect certification status.
Why WHO-GMP matters for export markets
For Indian pharmaceutical manufacturers supplying international markets, WHO-GMP certification is frequently a baseline requirement. Regulatory authorities in Africa, Southeast Asia, and the Middle East may require WHO-GMP compliance as a condition of product registration and import approval.
For domestic partners and multinational pharmaceutical companies, certification also signals documentation discipline and process control that make product transfer, partner manufacturing, and regulatory submissions more straightforward.
What a certified facility looks like in practice
- Controlled manufacturing environments: appropriate cleanroom classifications, air handling, and environmental monitoring.
- Validated processes: documented, reproducible manufacturing methods with formally investigated deviations.
- Raw-material traceability: testing on receipt and traceability from incoming material to finished-product release.
- Documented quality systems: standard operating procedures and complete batch manufacturing records.
- Trained personnel: qualified staff with documented training records available for regulatory review.
Swift Life Sciences and WHO-GMP compliance
Swift Life Sciences Pvt Ltd operates its dedicated non-beta lactam manufacturing facility in Rampur, Dehradun under WHO-GMP certification, alongside ISO 9001:2015 quality management accreditation.
The facility also holds NAFDAC and DAV Viet approvals, reflecting its ability to support regulatory requirements across African and Southeast Asian export markets.
Evaluating a pharmaceutical manufacturing partner?
Explore Swift's facility and certifications, review the product portfolio, or submit a verified business enquiry.